307
Participants
Start Date
July 31, 2010
Primary Completion Date
July 31, 2011
Study Completion Date
July 31, 2011
Rebif®
This is an retrospective cohort study in Pediatric participants including both children (aged less than 12 years) and adolescents (aged 12 to less than 18 years) who were exposed to Rebif® for treatment of demyelinating events (Dose regimen as per investigator's decision)
Research Site, Birmingham
Research Site, San Francisco
Research Site, Boston
Research Site, Buffalo
Research Site, Rochester
Research Site, Stoney Brook
Research Site, Buenos Aires
Research Site, Toronto
Research Site, Le Kremlin-Bicêtre
Research Site, Bari
Research Site, Catania
Research Site, Gallarate
Research Site, Milan
Research Site, Rome
Research Site, Torino
Research Site, Moscow
Research Site, Tunis
Research Site, Maracaibo
Lead Sponsor
EMD Serono
INDUSTRY